Novel Cationic 17-Estradiol-Substituted-Estradiol Derivatives with Anti-cancer Activity | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Novel Cationic 17-Estradiol-Substituted-Estradiol Derivatives with Anti-cancer Activity

Implementing Organization

Indian Institute of Chemical Engineers

Indian Institute of Chemical Technology (IICT)

About

Tested preclinically in triple negative breast tumor animal model (the most aggressive breast cancer model). The molecule is co-formulated in liposomes and developed further in association with Mayo Clinic, USA for treating multiple other aggressive cancers such as melanoma, pancreatic cancer.

Patent Details

EP2111409, IN263345, JP5276020, US8012952

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Cancer Treatment

Status

completed

Patent No.

EP2111409, IN263345, JP5276020, US8012952

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00